ARCT Q1 2021 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-19.6% YoY

Gross Profit

-$48M-2253.1% margin

Operating Income

-$58M-2711.1% margin

Net Income

-$56M-2649.1% margin

EPS (Diluted)

$-2.15

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$481M

Total Liabilities

$129M

Stockholders' Equity

$353M

Cash & Equivalents

$467M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-19.6%
Gross Profit	-$48M	$3M	-1911.1%
Operating Income	-$58M	-$9M	-509.4%
Net Income	-$56M	-$10M	-476.3%